Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years
Portfolio Pulse from Benzinga Insights
Over the past 15 years, Alnylam Pharmaceuticals (NASDAQ:ALNY) has produced an average annual return of 14.93%, outperforming the market by 1.77% on an annualized basis. With a current market capitalization of $18.95 billion, a $100 investment in ALNY 15 years ago would be worth $761.38 today. This showcases the impact of compounded returns on cash growth over time.
March 18, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alnylam Pharmaceuticals has demonstrated significant growth over the past 15 years, with an average annual return of 14.93%, outperforming the market. This long-term performance could attract more investors, looking for stable, high-growth opportunities.
The article highlights Alnylam Pharmaceuticals' impressive 15-year performance, outperforming the market with a 14.93% average annual return. This historical performance, coupled with its current market capitalization of $18.95 billion, positions ALNY as a potentially attractive investment. The significant growth from a $100 investment to $761.38 today underscores the company's strong performance and could lead to increased investor interest in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100